GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinclair Pharma PLC (XPAR:SPH) » Definitions » YoY Rev. per Sh. Growth

Sinclair Pharma (XPAR:SPH) YoY Rev. per Sh. Growth : 5.45% (As of Jun. 2018)


View and export this data going back to . Start your Free Trial

What is Sinclair Pharma YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Sinclair Pharma's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2018 was 5.45%.

Sinclair Pharma's Revenue per Share for the six months ended in Jun. 2018 was €0.06.


Sinclair Pharma YoY Rev. per Sh. Growth Historical Data

The historical data trend for Sinclair Pharma's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinclair Pharma YoY Rev. per Sh. Growth Chart

Sinclair Pharma Annual Data
Trend Jun07 Jun08 Jun09 Jun10 Jun11 Jun12 Jun13 Jun14 Jun15 Dec17
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.24 1.84 21.69 -50.99 32.32

Sinclair Pharma Semi-Annual Data
Jun08 Dec08 Jun09 Dec09 Jun10 Dec10 Jun11 Dec11 Jun12 Dec12 Jun13 Dec13 Jun14 Dec14 Jun15 Dec15 Jun16 Jun17 Dec17 Jun18
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.88 -8.77 120.00 30.77 5.45

Sinclair Pharma YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Sinclair Pharma's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2017 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2017 )
=(Revenue per Share (A: Dec. 2017 )-Revenue per Share (A: Jun. 2015 ))/ | Revenue per Share (A: Jun. 2015 ) |
=(0.131-0.099)/ | 0.099 |
=32.32 %

Sinclair Pharma's YoY Rev. per Sh. Growth for the quarter that ended in Jun. 2018 is calculated as:

YoY Rev. per Sh. Growth (Q: Jun. 2018 )
=(Revenue per Share (Q: Jun. 2018 )-Revenue per Share (Q: Jun. 2017 )) / | Revenue per Share (Q: Jun. 2017 )) |
=(0.058-0.055)/ | 0.055 |
=5.45 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinclair Pharma YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Sinclair Pharma's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinclair Pharma (XPAR:SPH) Business Description

Traded in Other Exchanges
N/A
Address
Sinclair Pharma PLC is a United Kingdom-based specialty pharmaceutical company focused on Dermatology, in particular, Aesthetics, Wound care, and Skin care. The group has a direct sales and marketing presence in the top five European markets and a rapidly growing International division concentrated on key emerging markets through long-term multi-product, multi-country, sales & marketing and distribution deals with key strategic partners. The Company's reportable operating segments are International Operations, France, Italy, Germany, UK, and Spain.